BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Treatment
524 results:

  • 1. New genetic insights into immunotherapy outcomes in gastric cancer via single-cell RNA sequencing and random forest model.
    Yu D; Yang J; Wang B; Li Z; Wang K; Li J; Zhu C
    Cancer Immunol Immunother; 2024 May; 73(6):112. PubMed ID: 38693422
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Clinical Impact of the Prognostic Immune and Nutritional Index in gastric cancer Patients Who Received Curative treatment.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Tamagawa A; Cho H; Morita J; Tanabe M; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
    Anticancer Res; 2024 May; 44(5):2231-2238. PubMed ID: 38677750
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Online tools to predict individualised survival for primary oesophageal cancer patients with and without pathological complete response after neoadjuvant therapy followed by oesophagectomy: development and external validation of two independent nomograms.
    Cao Y; Huang B; Tang H; Dong D; Shen T; Chen X; Feng X; Zhang J; Shi L; Li C; Jiao H; Tan L; Zhang J; Li H; Zhang Y
    BMJ Open Gastroenterol; 2024 Mar; 11(1):. PubMed ID: 38538088
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study.
    Chen X; Xu H; Chen X; Xu T; Tian Y; Wang D; Guo F; Wang K; Jin G; Li X; Wang R; Li F; Ding Y; Tang J; Fang Y; Zhao J; Liu L; Ma L; Meng L; Hou Z; Zheng R; Liu Y; Guan N; Zhang B; Tong S; Chen S; Li X; Shu Y
    Signal Transduct Target Ther; 2024 Mar; 9(1):73. PubMed ID: 38528050
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function.
    Wang SY; Wang YX; Shen A; Yang XQ; Liang CC; Huang RJ; Jian R; An N; Xiao YL; Wang LS; Zhao Y; Lin C; Wang CP; Yuan ZP; Yuan SQ
    Eur J Med Res; 2024 Mar; 29(1):180. PubMed ID: 38494472
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A predictive model for intraabdominal infection after radical gastrectomy in elderly patients.
    Yu X; Tang W; Bai C; Li R; Feng B; Wu J; Guo X; Chen H; Li M
    Medicine (Baltimore); 2024 Mar; 103(11):e37489. PubMed ID: 38489739
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Machine learning-based cell death signature for predicting the prognosis and immunotherapy benefit in stomach adenocarcinoma.
    Li F; Feng Q; Tao R
    Medicine (Baltimore); 2024 Mar; 103(10):e37314. PubMed ID: 38457593
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Perioperative or neoadjuvant chemotherapy for locally advanced gastric or gastroesophageal junction cancer: from independent evidence in the West, the East, and Japan to global collaboration.
    Nakayama I; Ohashi M; Nunobe S
    Chin Clin Oncol; 2024 Feb; 13(1):8. PubMed ID: 38453658
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Risk factors, prognostic factors, and nomograms for distant metastases in patients with gastroenteropancreatic neuroendocrine tumors: a population-based study.
    Li X; Fan Y; Tong J; Lou M
    Front Endocrinol (Lausanne); 2024; 15():1264952. PubMed ID: 38449852
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Expression patterns of E2Fs identify tumor microenvironment features in human gastric cancer.
    Li F; Yan J; Leng J; Yu T; Zhou H; Liu C; Huang W; Sun Q; Zhao W
    PeerJ; 2024; 12():e16911. PubMed ID: 38371373
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. TRANSCRIPTOME ANALYSIS REVEALED THE MOLECULAR SIGNATURES OF CISPLATIN-FLUOROURACIL COMBINED CHEMOTHERAPY RESISTANCE IN gastric cancer.
    Luo Y; Chen X; Hu E; Wang L; Yang Y; Jiang X; Zheng K; Wang L; Li J; Xu Y; Wang Y; Xie Y
    Georgian Med News; 2023 Dec; (345):6-18. PubMed ID: 38325291
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A ubiquitination-related risk model for predicting the prognosis and immunotherapy response of gastric adenocarcinoma patients.
    Shao S; Sun Y; Zhao D; Tian Y; Yang Y; Luo N
    PeerJ; 2024; 12():e16868. PubMed ID: 38313020
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The macrophage-associated prognostic gene ANXA5 promotes immunotherapy resistance in gastric cancer through angiogenesis.
    Hong Z; Wen P; Wang K; Wei X; Xie W; Rao S; Chen X; Hou J; Zhuo H
    BMC Cancer; 2024 Jan; 24(1):141. PubMed ID: 38287304
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Development and validation of nomogram for predicting early recurrence after radical gastrectomy of gastric cancer.
    Cao M; Hu C; Pan S; Zhang Y; Yu P; Zhang R; Cheng X; Xu Z
    World J Surg Oncol; 2024 Jan; 22(1):21. PubMed ID: 38243254
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study.
    Wu Z; Shang G; Zhang K; Wang W; Fan M; Lin R
    Int J Surg; 2024 Apr; 110(4):2178-2186. PubMed ID: 38241384
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prediction Model of Ocular Metastases in gastric Adenocarcinoma: Machine Learning-Based Development and Interpretation Study.
    Zou J; Shen YK; Wu SN; Wei H; Li QJ; Xu SH; Ling Q; Kang M; Liu ZL; Huang H; Chen X; Wang YX; Liao XL; Tan G; Shao Y
    Technol Cancer Res Treat; 2024; 23():15330338231219352. PubMed ID: 38233736
    [No Abstract]    [Full Text] [Related]  

  • 17. Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902).
    Kawase T; Imamura H; Kawabata R; Matsuyama J; Nishikawa K; Yanagihara K; Yamamoto K; Hoki N; Kawada J; Kawakami H; Sakai D; Kurokawa Y; Shimokawa T; Satoh T
    Int J Clin Oncol; 2024 Feb; 29(2):134-141. PubMed ID: 38227090
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. gastric cancer mesenchymal stem cells promote tumor glycolysis and chemoresistance by regulating B7H3 in gastric cancer cells.
    Gao Q; Huang C; Liu T; Yang F; Chen Z; Sun L; Zhao Y; Wang M; Luo L; Zhou C; Zhu W
    J Cell Biochem; 2024 Mar; 125(3):e30521. PubMed ID: 38226525
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Precutting endoscopic band ligation-assisted resection versus endoscopic submucosal dissection in patients with small gastric submucosal tumors originating from the muscularis propria: study protocol of a randomized controlled trial.
    Liu M; Yuan R; Zhan K; Yang Y; Li S; Deng L
    Trials; 2024 Jan; 25(1):49. PubMed ID: 38218850
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. An international Delphi consensus for surgical quality assessment of lymphadenectomy and anastomosis in minimally invasive total gastrectomy for gastric cancer.
    Cizmic A; Romic I; Balla A; Barabino N; Anania G; Baiocchi GL; Bakula B; Balagué C; Berlth F; Bintintan V; Bracale U; Egberts JH; Fuchs HF; Gisbertz SS; Gockel I; Grimminger P; van Hillegersberg R; Inaki N; Immanuel A; Korr D; Lingohr P; Mascagni P; Melling N; Milone M; Mintz Y; Morales-Conde S; Moulla Y; Müller-Stich BP; Nakajima K; Nilsson M; Reeh M; Sileri P; Targarona EM; Ushimaru Y; Kim YW; Markar S; Nickel F; Mitra AT
    Surg Endosc; 2024 Feb; 38(2):488-498. PubMed ID: 38148401
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 27.